Navigation Links
Atlantic Peptides, a Synthetic Peptide Manufacturer, Unveils Its New Website for Easier Navigation
Date:11/5/2013

Scarborouth, Maine (PRWEB) November 05, 2013

Atlantic Peptides, a synthetic peptide manufacturer, unveils its new website for easier navigation.

Atlantic Peptides (http://www.atlanticpeptides.com/), a synthetic peptide manufacturer and polyclonal and monoclonal antibody supplier, announces the launch of its new website. The updated site marks Atlantic Peptide’s initiative to reach an even broader national and international audience through the life-science and academia industries.

Atlantic Peptides announces the launch of its new website design, which facilitates easier user navigation. Atlantic Peptides is a synthetic peptide manufacturer and supplier of polyclonal and monoclonal antibodies to national and international academia and science industries. The Scarborough-based business also works with the pharmaceutical industries by supplying therapeutic initiatives with peptides for research studies.

The website features updated, in-depth coverage of the types of products Atlantic Peptides offers, such as custom peptides for the production of antibodies. As detailed by the new website, services also include the evaluation and analysis of peptides prior to synthesis by the use of hydrophobicity plots, evaluation of the stability and solubility of peptides, as well as the analysis of secondary structure formations, and more.

The site additionally houses an easy-to-use Peptide Library that serves as a useful resource, describing industry-relevant terms like overlapping peptide library, truncation peptide library, alanine peptide scanning library, and random peptide library for those interested in learning about term variations.

Atlantic Peptides is partnered with a United Kingdom company to provide cGMP services to support the various stages of clinical studies, from pre-clinical toxicology studies to early stage trials. The facility spans more than 10,000 square feet with eight cGMP suites, and was designed to meet and exceed national and international standards. Access-controlled facilities include a laminar flow Grade A cabinet, and built-in and walk-in fume cabinets.

About Atlantic Peptides

Atlantic Peptides manufactures synthetic peptides, as well as provides mono- and poly-clonal antibodies to the academic and life-science industries across the world. Atlantic Peptides also offers personalized, custom services to address individual business needs, and also works with pharmaceutical industries for research studies.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11297124.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Atlantic Shores Retirement Community Develops Cutting-Edge Program for CCRC Patient Care
2. Keiretsu Forum Mid-Atlantic Launches July Four-City Road Show
3. MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel
4. Atlantic Peptides Teams Up with a United Kingdom Company to Offer cGMP Peptides and API
5. Atlantica Group LLC to Support International "Soft-Landing" Efforts of Incubators and Accelerators
6. Atlantica Group LLC to Support Global Business Incubation and "Soft Landing" Efforts
7. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
8. Human Genome Decoder and Artificial Life Creator, J. Craig Venter to Speak at "The Atlantic Meets the Pacific"
9. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
10. Waters Unveils Industrys First Integrated LC/MS Platform for Proteins, Peptides, and Glycans Analysis at WCBP 2013
11. Synthetic Biologics Responds to Recent CDC Report on Threat of "Super Bugs"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):